- Joined
- 4 Jun 2021
- Messages
- 5,536 (4.54/day)
Turns out that semaglutide offers benefits beyond just treating diabetes and obesity, but helps to fight many diseases, so could end up being prescribed on the NHS to people without these conditions.
It has been eight years since weight-loss drug Ozempic hit the market, while Wegovy surfaced in 2021. Since then many reports have been written about the wider health benefits of the so called wonder drugs.
Ozempic and Wegovy, which contain a medication called semaglutide, are manufactured by Novo Nordisk. Both drugs can be used by those with type 2 diabetes to help aid weight loss and manage blood sugar levels. However, Wegovy has since been approved in the UK to aid weight loss in those without diabetes. Since their launch, the pharma giant has seen a boom in profits, and it isn’t surprising to see why.
Research published this week claimed the drug, could slow down ageing and has “far-reaching benefits” beyond what was originally imagined.
Ozempic hailed as ‘fountain of youth’
Ozempic could offer “the fountain of youth” and turn back the clock on a host of diseases, scientists have found.
uk.news.yahoo.com